Patents by Inventor Greg Hardee

Greg Hardee has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20120309815
    Abstract: The present invention relates to compositions and methods which enhance the delivery of nucleic acids and other nucleosidic moieties via topical routes of administration. The invention relates to the use of an aqueous solution to preferentially deliver nucleic acids preferentially to hair follicles. The invention relates to a method of inhibiting hair growth comprising administration of a nucleic acid preferentially to a hair follicle.
    Type: Application
    Filed: April 4, 2012
    Publication date: December 6, 2012
    Applicant: ISIS PHARMACEUTICALS, INC.
    Inventors: Sujatha Dokka, Scott Cooper, Susan Kelly, Greg Hardee, James G. Karras
  • Publication number: 20050238606
    Abstract: The present invention relates to compositions and methods which enhance the delivery of nucleic acids and other nucleosidic moieties via topical routes of administration. The invention relates to the use of an aqueous solution to preferentially deliver nucleic acids preferentially to hair follicles. The invention relates to a method of inhibiting hair growth comprising administration of a nucleic acid preferentially to a hair follicle.
    Type: Application
    Filed: April 21, 2005
    Publication date: October 27, 2005
    Inventors: Sujatha Dokka, Scott Cooper, Susan Kelly, Greg Hardee, James Karras
  • Patent number: 6887906
    Abstract: The present invention relates to compositions and methods which enhance the transport of nucleic acids, especially oligonucleotides at various sites in the alimentary canal of an animal. The methods and compositions enhance the transport of oligonucleotides across the mucosa of the alimentary canal via the use of one or more penetration enhancers. The invention features the use of various fatty acids, bile salts, chelating agents and other penetration enhancers, as well as carrier compounds, to enhance the stability of nucleic acids and/or their transport across and/or into cells of the alimentary canal. In one preferred embodiment, the compositions and methods of the invention are utilized to effect the oral delivery of an antisense oligonucleotide to an animal in order to modulate the expression of a gene in the animal for investigative, therapeutic or prophylactic purposes.
    Type: Grant
    Filed: July 1, 1998
    Date of Patent: May 3, 2005
    Assignee: ISISPharmaceuticals, Inc.
    Inventors: Ching-Leou Teng, Greg Hardee